Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

0
Player Avatar targetphil3 (< 20) Submitted: 9/7/2010 7:37:50 PM : Outperform Start Price: $51.39 AMGN Score: +13.68

banking on upcoming phase III results

Report this Post Reply

Featured Broker Partners


Advertisement